Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

STO/VICO stock hub

STO/VICO has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

STO/VICOis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

Nasdaq Stockholm

Market data

Live price

Current market quote for this ticker.

Current price

STO/VICO

In the news

Latest news · STO/VICO

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-47.2

P25 n/aP50 n/aP75 n/a

ROIC-29.7

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All STO/VICO market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

158

Groups with data

Currency

SEK

Showing 158 of 158 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Sweden
Country code	SE
Employees	36
Employees Change	7%
Employees Change Percent	24.14
Enterprise value	SEK 2B
Exchange	Nasdaq Stockholm
Financial currency	SEK
First seen	2026-05-10
Industry	Biotechnology
Isin	SE0007577895
Last refreshed	2026-05-10
Market cap	SEK 3B
Price	SEK 10.74
Price currency	SEK
Rev Per Employee	95,324.32x
Sector	Healthcare
Sic	2836
Symbol	sto/VICO
Website	https://www.vicorepharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-15.7%
EV Earnings	-4.14x
P/B ratio	3.05x
P/S ratio	857.27x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	370.57%
Gross Profit	SEK 13.1M
Gross Profit Growth	5.32%
Gross Profit Growth Q	1,756.5%
Net Income	SEK -474.6M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-13,452.48%
Profit Per Employee	SEK -12.8M
ROA	-27.61
Roa5y	-34.77
ROCE	-48.08
ROE	-47.19
Roe5y	-62.78
ROIC	-29.66

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	7.39%
Cagr1y	39.51%
Cagr3y	-18.51%
Cagr5y	-14.6%
EPS Growth Quarters	4
EPS Growth Years	0
Revenue Growth	-41.17x
Revenue Growth Q	-32.51x
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	SEK 0
Assets	SEK 1.1B
Cash	SEK 1.1B
Current Assets	SEK 1.1B
Current Liabilities	SEK 84.7M
Equity	SEK 990.9M
Liabilities	SEK 86.4M
Long Term Assets	SEK 3M
Long Term Liabilities	SEK 1.7M
Net Cash	SEK 1.1B
Net Cash By Market Cap	SEK 35.05
Net Cash Growth	1.05%
Net Debt Equity	SEK -1.07
Tangible Book Value	SEK 990.9M
Tangible Book Value Per Share	SEK 3.56
WACC	5

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	12.69
Net Working Capital	SEK -70.2M
Quick ratio	12.57
Working Capital	SEK 989.6M
Working Capital Turnover	SEK 0

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-50.54%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	104.05%
1Y total return	39.48%
200-day SMA	10.69
3Y total return	-45.89%
50-day SMA	10.09
50-day SMA vs 200-day SMA	50under200
5Y total return	-54.57%
All Time High	40
All Time High Change	-73.15%
All Time High Date	2017-07-20
All Time Low	5.7
All Time Low Change	88.42%
All Time Low Date	2016-02-25
ATR	0.46
Beta	0.14
Beta1y	0.9
Beta2y	0.58
Ch YTD	-4.96
High	11.16
High52	14.1
High52 Date	2025-09-30
High52ch	-23.83%
Low	10.5
Low52	7.35
Low52 Date	2025-07-14
Low52ch	46.12%
Ma50ch	6.4%
Price vs 200-day SMA	0.48%
RSI	60.61
RSI Monthly	47.15
RSI Weekly	52.58
Sharpe ratio	0.68x
Sortino ratio	1.29
Total Return	-50.54%
Tr YTD	-4.96
Tr1m	10.38%
Tr1w	7.72%
Tr3m	3.87%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	SEK -477.2M
Operating margin	-13,530

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	198,621,158%
Shares Insiders	4.88%
Shares Institutions	33.87%
Shares Out	281,525,593
Shares Qo Q	8.89%
Shares Yo Y	50.54%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	440,386.3x
Bv Per Share	3.56
Ch10y	45.14
Ch1m	10.38
Ch1w	7.72
Ch1y	39.48
Ch3m	3.87
Ch3y	-47.35
Ch5y	-55.8
Ch6m	4.27
Change	1.9%
Change From Open	1.9
Close	10.54
Days Gap	0
Dollar Volume	5,643,633.7
Earnings Date	2026-05-06
EBIT	SEK -477.2M
EPS	SEK -1.89
F Score	2
Financing CF	430,544,000
Fiscal Year End	December
Founded	2,000
Income Tax	SEK 86,000
Investing CF	-355,323,000
Is Primary Listing	1
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Ma150	10.69
Ma150ch	0.44%
Ma20	10.21
Ma20ch	5.18%
Net CF	-338,049,000
Next Earnings Date	2026-08-21
Open	10.54
Position In Range	36.36
Price Date	2026-05-08
Ptbv Ratio	3.05
Relative Volume	1.23x
Revenue	3,527,000x
Tax By Revenue	2.44x
Tr6m	4.27%
Volume	525,478

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does STO/VICO pay a dividend?

Capital-return profile for this ticker.

Performance

STO/VICO stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns STO/VICO?

Insider, institutional, and short-interest positioning.

Institutional ownership

+33.9%

Share of float held by funds and institutions

Insider ownership

+4.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+50.5%

Negative means the company is buying back shares.

Technical

STO/VICO momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

60.6

Neutral momentum band

Price vs 200-day MA

+0.5%

50/200-day relationship not available

Beta (5Y)

0.14

Less volatile than the market

Sharpe ratio

0.68

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About STO/VICO

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sto/VICO stock rating?

sto/VICO is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sto/VICO analysis?

The full report lives at /stocks/sto/VICO/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sto/VICO?

The latest report frames sto/VICO around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sto/VICO page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.